A Silicon Valley entrepreneur has revealed some of the negative symptoms he experiences from his dedication to trying to ‘live forever’.
Bryan Johnson has long been raising eyebrows with his intense lifestyle for the ultimate goal of ‘reversing aging’.
The entrepreneur - who is the focus of Netflix's Don't Die: The Man Who Wants to Live Forever - was born 47 years ago but has taken a whole lot of steps to ensure that he looks younger and feels younger, but it isn’t without its issues.
Advert
According to Johnson, his mission has helped him achieve the 'heart of 37-year-old' and the 'lung capacity of an 18-year-old' but it certainly hasn’t been easy.
In fact, his typical day sounds a lot more draining and painful than the average person.
The biohacker has been open about the procedures he's undergone to reverse his age, including having his DNA 'edited', injecting himself with stem cells and exchanging blood with his son. So, you know he is serious about staying young forever.
Advert
But recently, writing on his Twitter page, Johnson said he was dropping rapamycin, a cancer drug that was shown to have some anti-aging effects in mice trials.
He explained that he had been taking it for years, but he and his team decided to drop the drug.
Johnson said: “Despite the immense potential from pre-clinical trials, my team and I came to the conclusion that the benefits of lifelong dosing of Rapamycin do not justify the hefty side-effects.”
Advert
He continued: “Intermittent skin/soft tissue infections, lipid abnormalities, glucose elevations, and increased resting heart rate). With no other underlying causes identified, we suspected Rapamycin, and since dosage adjustments had no effect, we decided to discontinue it entirely.”
And to make matters worse, Johnson even suggested that there is evidence to say it actually increases aging. You know... the opposite of what he is attempting.
He added: “Additionally, on October 27th, a new pre-print [5] indicated that Rapamycin was one of a handful of supposed longevity interventions to cause an increase/acceleration of aging in humans across 16 epigenetic aging clocks.
Advert
“This type of evaluation is the first of its kind, as most longevity interventions up to date have been tested against one or two aging clocks, leading to invisible biases and potential intended 'cherry picking' of favorable clocks for the tested interventions.”
Johnson said that more research is needed on the topic as the ‘experimental compounds is constantly evolving’.
With that said, I think I'll just deal with getting older naturally.
Topics: Bryan Johnson, Health, Drugs
Gerrard Kaonga